Lemborexant is an orexin receptor antagonist medication used for the treatment of insomnia, functioning by blocking orexin signaling to support both sleep onset and maintenance. To ensure the safety and… Read more









Lemborexant is an orexin receptor antagonist medication used for the treatment of insomnia, functioning by blocking orexin signaling to support both sleep onset and maintenance. To ensure the safety and efficacy of this therapeutic agent, pharmaceutical laboratories rely on a comprehensive suite of reference materials for rigorous analytical testing and quality control. This category includes high-quality reference standards for the parent drug, as well as its known and non-pharmacopeial impurities, specific stereoisomers, and metabolic degradation products. Additionally, stable isotope labelled compounds are available to serve as internal standards for accurate quantification in complex biological matrices. By utilizing these materials, researchers can perform precise impurity profiling, conduct robust method validation, and maintain strict regulatory compliance throughout the development and manufacturing lifecycle of the drug.